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Background: The lectin-like domain of TNF-α mimicked by an inhaled TIP peptide represents a novel approach to
attenuate a pulmonary edema in respiratory failure, which is on the threshold to clinical application. In extension to
a previously published study, which reported an improved pulmonary function following TIP peptide inhalation in a
porcine model of lavage-induced lung injury, a post-hoc comparison to additional experiments was conducted.
This analysis addresses the hypothesis that oleic acid injection-induced capillary leakage and alveolar necrosis blunts
the previously reported beneficial effects of TIP peptide inhalation in a porcine model.
Findings: Following animal care committee approval lung injury was induced by oleic acid injection in six pigs
with a setting strictly according to a previously published protocol that was used for lung-lavaged pigs. Ventilation/
perfusion-distribution by multiple inert gas elimination, parameters of gas exchange and pulmonary edema were
assessed as surrogates of the pulmonary function. A significantly improved ventilation/perfusion-distribution
following TIP inhalation was recognized only in the bronchoalveolar lavage model but not following oleic acid
injection. The time course after oleic acid injection yielded no comparable impact of the TIP peptide on gas
exchange and edema formation.
Conclusions: Reported beneficial effects of the TIP peptide on gas exchange and pulmonary edema were not
reproducible in the oleic acid injection model. This analysis assumes that sustained alveolar epithelial necrosis as
induced by oleic acid injection may inhibit the TIP-induced edema resolution. Regarding the on-going clinical
development of the TIP peptide this approach should hardly be effective in states of severe alveolar epithelial
damage.
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Background
In extension to a previously published study [1] a post-hoc
comparison to additionally acquired data was performed.
The lectin-like domain of TNF-α mimicked by an inhaled
TIP peptide is a novel pharmacologic approach for treat-
ment of edematous respiratory failure and acute respiratory
distress syndrome (ARDS) [2]. In several experimental
models TIP peptides were shown to attenuate pulmonary
edema formation [3-6]. The TIP peptide primarily stimu-
lates epithelial sodium channels on type II alveolar cells to
enhance sodium transfer across the alveolar epithelium.* Correspondence: hartmane@uni-mainz.de
1Department of Anaesthesiology, Medical Centre of the Johannes
Gutenberg-University, Langenbeckstr. 1, 55131 Mainz, Germany
Full list of author information is available at the end of the article
© 2013 Hartmann et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orThis generates an osmotic gradient and allows the absorp-
tion of an alveolar edema, whereas this effect can be
inhibited by pharmacologic blockade of the epithelial so-
dium channels [3-5]. Furthermore, the TIP peptide reduces
microvascular hyperpermeability, which prevents a further
edema formation [4,7], and was found to reduce inflamma-
tory response and reactive oxygen species generation in rat
model of ischemia and reperfusion-related lung injury [6].
Despite proceeding to the early clinical study phase only
few data of TIP peptide application are available from
clinical-like in vivo models. Our group found a significantly
improved pulmonary function when an inhaled TIP
peptide was compared to placebo in a porcine model of
lung lavage/surfactant-depletion (LAV)-induced lung
injury [1]. This finding was primarily attributed to reso-
lution of pulmonary edema through the TIP peptide asral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Study data
Parameter ARDS-baseline 3 hours
OAI LAV [1] OAI LAV [1]
paO2/FiO2 [mmHg] 172 (91) 157 (59) 203 (151) 260 (63)*
EVLWI [ml kg-1] 14 (4) 15 (2) 13 (2) 13 (1)*
Cdyn[ml cmH2O
-1] 16 (2) 15 (3) 13 (3)* 17 (4)
Vt [ml kg
-1] 9.9 (0.5) 10.0 (0.2) 10.2 (0.5) 9.8 (1.4)
PEEP [cmH2O] 0.6 (0.1) 0.5 (0.1) 0.7 (0.6) 0.7 (0.4)
RR [min-1] 27 (3) 25 (4) 27 (4) 26 (4)
Pendinsp [cmH2O] 16 (2) 19 (4) 20 (4) 18 (2)
FiO2 1.0 1.0 1.0 1.0
etCO2 [mmHg] 43 (4) 38 (4) 36 (2) 37 (4)
PaCO2 [mmHg] 68 (12) 59 (9) 48 (18) 45 (4)
MAP [mmHg] 97(13) 108 (15) 82 (5) 86 (16)
MPAP [mmHg] 45 (7) 20 (7) # 31 (5)* 19 (5) #
CO [l min-1] 3.9 (0.2) 4.0 (1.0) 3.4 (0.3) 3.6 (0.5)
PVR [dyn s cm-5] 584 (265) 187 (158) # 349 (175)* 183 (124) #
Data expressed as median (interquartile range). * indicates P < 0.05 vs. ARDS
baseline value, # indicates P < 0.05 in intergroup comparison vs. OAI.
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Na+-K+-ATPase in the intact alveolar epithelium.
Hence, an intact alveolar epithelium should be critical
for the efficiency and clinical benefit of the TIP peptide
in an in vivo setting. Oleic acid injection (OAI) is an-
other proven ARDS model that is primarily based on
inducing capillary leakage and epithelial necrosis [8].
We hypothesized that beneficial effect of the TIP
peptide would be blunted by OAI. A post-hoc analysis
therefore compared lung injured pigs by OAI to a previ-
ous study [1].
Material and methods
Following approval of the state and institutional animal
care committee (Landesuntersuchungsamt Rheinland-Pfalz,
Koblenz, Germany) six pigs were prospectively examined
and post-hoc compared to six randomly selected animals
with LAV-induced lung injury to provide further insights of
model-dependent characteristics of the TIP peptide.
Anesthesia, experimental procedure, monitoring and
ventilator settings were strictly adapted to the previous
study. The OAI group (n = 6) received an intravenous
application of oleic acid solved in balanced electrolyte
solution in a ratio of 1:10. The oleic acid was then ap-
plied in fractions of 1–2 ml over thirty minutes. Short-
term hemodynamic instability, which regularly occurs
immediately after injection, was treated by norepineph-
rine boli of 5–10 μg. To provide comparable baseline
conditions the procedure was continued until the quo-
tient of arterial partial pressure of oxygen and inspired
oxygen fraction was < 250 mmHg over 30 minutes or a
dose maximum of 0.3 ml kg-1 was administered. Starting
with the lung injury induction, all animals were venti-
lated in a constant mode that aims to avoid lung
protective effects: tidal volume 10 ml kg-1, positive end-
expiratory pressure 0 cmH2O, fraction of inspired oxy-
gen 1.0 and respiratory frequency 25–35 min-1 targeted
to an end-tidal carbon dioxide level < 60 mmHg. The TIP
peptide (1 mg kg-1; AP301, APEPTICO, Vienna, Austria)
was prepared and administered by nebulization once
stable ARDS conditions were achieved. The animals
were monitored over three hours after TIP peptide in-
halation. The ventilation/perfusion-distribution (VA/Q)
measured by micropore membrane inlet mass spec-
trometry – multiple inert gas elimination (MMIMS-
MIGET, Oscillogy LLC, PA, USA) was assessed as main
parameter in a previously described manner [9,10]. VA/
Q data was also available from the previous study. Add-
itionally, parameters of gas exchange, extravascular lung
water by transpulmonary thermodilution and respira-
tory mechanics (dynamic lung compliance) were exam-
ined. At the end of the protocol the animals were killed
in deep general anesthesia by central venous potassium
injection (20 mval).Parameters are given as median and interquartile
range. Intergroup comparison of the ventilation/perfu-
sion-distribution was conducted by the Mann–Whitney-
U-Test. Time courses of main parameters from the OAI
group were analyzed by Friedman-Test with post-hoc
Dunn-Test. P values lower than 0.05 were regarded as
different. Comparisons between the previously published
study at baseline and after three hours and the OAI
group were drawn at baseline and after three hours by
non-parametric testing in explorative manner with de-
scriptive P values (Table 1).
Results and conclusions
Comparable baseline conditions for the two models (LAV,
OAI) were achieved in terms of VA/Q, gas exchange, pul-
monary edema. Hemodynamics remained stable without
vasopressor support over three hours in both groups. Ven-
tilator settings and hemodynamics showed no relevant dif-
ferences other than higher values of mean pulmonary
arterial pressure and pulmonary vascular resistance in the
OAI group, which can be explained by different model fea-
tures respectively specific characteristics of OAI (Table 1).
Within three hours after TIP inhalation the overall lung
function as measured by VA/Q distribution approved a sig-
nificantly higher fraction of normal ratios (P = 0.004 vs.
OAI group) and a lower amount a poorly ventilated lung
areas (low VA/Q, P = 0.009 vs. OAI group; Figure 1) in the
LAV group. As previously reported [1] the LAV group
showed an increase of oxygenation and decrease of extra-
vascular lung water content after TIP inhalation (Table 1).
These findings were not reproducible in the OAI group
(Figure 2). In the OAI group an on-going worsening of
Figure 1 Ventilation/perfusion-distribution (VA/Q) in both groups. Comparable baseline conditions (left) and significantly improved VA/Q in
the LAV group within three hours (right).
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Despite the improved VA/Q in the LAV group and the
clearly opposing time courses (Table 1) no intergroup dif-
ferences of these additional surrogate parameters were de-
tectable in the post-hoc comparison.
The study has some limitations. At first, only a post-
hoc comparison to another study [1] was performed.
The availability of additional VA/Q as well as previously
published data, a small but distinct hypothesis and ani-
mal care reasons may though justify this approach. Ex-
perimental setup, TIP peptide dosage and physiologic
variables were accordingly predetermined.Figure 2 Time courses of oxygenation (PaO2/FiO2), dynamic lung com
# indicates P < 0.05 vs. baseline value.Different model kinetics may interfere with these re-
sults. However, the histopathological correlates of LAV
and OAI in pigs have been characterized in detail by our
group: accordingly, a higher grade of epithelial necrosis
occurs in the OAI model, though not necessarily a more
severe gas exchange impairment [11]. OAI also interacts
with the Na+-K+-ATPase on the basolateral side of type
II alveolar cells and therefore prohibits the alveolar fluid
clearance [12]. The LAV model, however, to some ex-
tent maintains the alveolar epithelial function [8,11,13].
A sustained improvement was found within three hours
in the LAV model [1]. This analysis indicates that inpliance (Cdyn) and extravascular lung water content (EVLWI).
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measurable effect after TIP inhalation. Furthermore, the
VA/Q was significantly ameliorated in the LAV group in
comparison to the OAI group. This different response
pattern may possibly be related to the higher amount of
epithelial destruction in the OAI model. Our hypothesis
therefore was approved. These data vice versa can be
interpreted as confirmation that in porcine models the en-
hancement of the alveolar fluid clearance rather than at-
tenuation of hyperpermeability or inflammatory response
is the main mechanism of TIP peptide inhalation. The ap-
ical side of the alveolar epithelium represents the TIP pep-
tide’s main side of action [5,6]. Due to the ongoing clinical
development of the TIP peptide these findings may have
further relevancy: based on these considerations regarding
the model characteristics the TIP peptide should require
an intact alveolar epithelial function. Further research
needs to determine, if this new approach can be effective
in states of profound alveolar destruction like in longer
established or persisting ARDS or only in early states that
are primarily characterized by edematous respiratory fail-
ure and less alveolar necrosis. In summary, this report
further elucidates the underlying mechanisms of the TIP
peptide inhalation as potential pharmacotherapy in re-
spiratory failure or ARDS.
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